Navigo Invest Q2 2024: Roughly in line, variations among subsidiaries - Redeye
Redeye provides its initial take on Navigo’s Q2 2024 report, which came in just slightly below our estimates. We judge that positives from the report include better-than-expected sales and profits of Vinga Group, while Chemgroup’s and Geogruppen’s figures roughly aligned with our projections. Notable negatives include CalorMet underperforming our estimates. We judge Navigo posted a solid quarter and believe there exists a decent chance that NAV per common share has bottomed in H1 2024.
Länk till analysen i sin helhet: https://www.redeye.se/research/1032930/navigo-invest-q2-2024-roughly-in-line-variations-among-subsidiaries?utm_source=finwire&utm_medium=RSS